JP2010511665A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010511665A5 JP2010511665A5 JP2009539730A JP2009539730A JP2010511665A5 JP 2010511665 A5 JP2010511665 A5 JP 2010511665A5 JP 2009539730 A JP2009539730 A JP 2009539730A JP 2009539730 A JP2009539730 A JP 2009539730A JP 2010511665 A5 JP2010511665 A5 JP 2010511665A5
- Authority
- JP
- Japan
- Prior art keywords
- formulation
- rabies virus
- antibody
- temperature
- chain seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87289206P | 2006-12-05 | 2006-12-05 | |
| EP06125400.9 | 2006-12-05 | ||
| US60/872,892 | 2006-12-05 | ||
| EP06125400 | 2006-12-05 | ||
| PCT/EP2007/063244 WO2008068246A1 (en) | 2006-12-05 | 2007-12-04 | Liquid anti-rabies antibody formulations |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010511665A JP2010511665A (ja) | 2010-04-15 |
| JP2010511665A5 true JP2010511665A5 (enExample) | 2011-01-20 |
| JP5410985B2 JP5410985B2 (ja) | 2014-02-05 |
Family
ID=39092188
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009539730A Expired - Fee Related JP5410985B2 (ja) | 2006-12-05 | 2007-12-04 | 液体抗狂犬病抗体製剤 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7959922B2 (enExample) |
| EP (1) | EP2088997B1 (enExample) |
| JP (1) | JP5410985B2 (enExample) |
| KR (1) | KR101522036B1 (enExample) |
| CN (1) | CN101557799B (enExample) |
| AU (1) | AU2007328960B2 (enExample) |
| CA (1) | CA2668947C (enExample) |
| CU (1) | CU23795A3 (enExample) |
| EA (1) | EA017549B1 (enExample) |
| IL (1) | IL199004A (enExample) |
| MX (1) | MX2009005414A (enExample) |
| WO (1) | WO2008068246A1 (enExample) |
| ZA (1) | ZA200902772B (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2322547A1 (en) | 2003-06-25 | 2011-05-18 | Crucell Holland B.V. | Myeloid cell-specific lectin |
| EP2314620B1 (en) * | 2004-05-27 | 2013-06-05 | Crucell Holland B.V. | Method of identifying binding molecules capable of neutralizing rabies virus |
| CA2881717C (en) * | 2006-06-06 | 2018-06-12 | Cecilia Anna Wilhelmina Geuijen | Human binding molecules having killing activity against staphylococci and uses thereof |
| JP5410985B2 (ja) | 2006-12-05 | 2014-02-05 | クルセル ホランド ベー ヴェー | 液体抗狂犬病抗体製剤 |
| JP2010085126A (ja) * | 2008-09-29 | 2010-04-15 | Adtec Kk | 狂犬病ウイルス中和抗体価判定具および狂犬病ウイルス中和抗体価の測定方法 |
| US8821879B2 (en) | 2009-09-04 | 2014-09-02 | Xoma Technology Ltd. | Anti-botulism antibody coformulations |
| CN107233569B (zh) | 2011-10-25 | 2021-08-31 | 普罗西纳生物科学有限公司 | 抗体制剂和方法 |
| RS55417B1 (sr) * | 2012-03-07 | 2017-04-28 | Lilly Co Eli | Formulacija il-17 antitela |
| UA117466C2 (uk) | 2012-12-13 | 2018-08-10 | Мерк Шарп Енд Доме Корп. | СТАБІЛЬНИЙ СКЛАД У ВИГЛЯДІ РОЗЧИНУ АНТИТІЛА ДО IL-23p19 |
| KR20140119396A (ko) | 2013-03-29 | 2014-10-10 | 삼성전자주식회사 | 단백질 약물의 액상 제형 |
| JOP20190260A1 (ar) | 2017-05-02 | 2019-10-31 | Merck Sharp & Dohme | صيغ ثابتة لأجسام مضادة لمستقبل الموت المبرمج 1 (pd-1) وطرق استخدامها |
| JP7382232B2 (ja) | 2017-05-02 | 2023-11-16 | メルク・シャープ・アンド・ドーム・エルエルシー | 抗ｌａｇ３抗体の製剤および抗ｌａｇ３抗体と抗ｐｄ－１抗体との共製剤 |
| JP7159642B2 (ja) * | 2018-06-26 | 2022-10-25 | 東ソー株式会社 | カラムの抗体に対する保持力の測定方法 |
| WO2020081408A1 (en) | 2018-10-18 | 2020-04-23 | Merck Sharp & Dohme Corp. | Formulations of anti-rsv antibodies and methods of use thereof |
| MX2021004928A (es) | 2018-10-31 | 2021-06-08 | Merck Sharp & Dohme Llc | Cristales de anticuerpo anti-pd-1 humano y metodos de uso de los mismos. |
| EP3876990A4 (en) | 2018-11-07 | 2023-09-06 | Merck Sharp & Dohme LLC | CO-FORMULATIONS OF ANTI-LAG3 ANTIBODIES AND ANTI-PD-1 ANTIBODIES |
| TWI878554B (zh) | 2020-06-12 | 2025-04-01 | 大陸商南京維立志博生物科技股份有限公司 | 結合ｔｎｆｒ２的抗體及其用途 |
| CN114748618B (zh) * | 2022-04-02 | 2024-07-19 | 重庆智翔金泰生物制药股份有限公司 | 包含针对狂犬病病毒g蛋白的双特异性抗体的药物制剂及其制备方法 |
| CN117771365B (zh) * | 2023-12-07 | 2025-07-04 | 兰州生物制品研究所有限责任公司 | 一种抗狂犬病病毒组合单克隆抗体制剂 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE99958T1 (de) | 1989-06-08 | 1994-01-15 | Wistar Inst | Monoklonale antikoerper zur behandlung nach einem kontakt mit tollwutvirus. |
| DE4006630A1 (de) | 1990-03-03 | 1991-09-12 | Behringwerke Ag | Humane monoklonale antikoerper gegen tollwutviren, ihre herstellung und verwendung |
| DK0934526T3 (da) | 1996-10-08 | 2003-05-05 | Bisys B V U | Fremgangsmåder og midler til udvælgelse af peptider og proteiner, der har specifik affinitet til et mål |
| US20040013672A1 (en) * | 2000-05-16 | 2004-01-22 | Thomas Jefferson University | Recombinant antibodies, and compositions and methods for making and using the same |
| WO2003016501A2 (en) | 2001-08-21 | 2003-02-27 | Thomas Jefferson University | Recombinant antibodies, and compositions and methods for making and using the same |
| DK2314629T4 (da) | 2002-07-18 | 2023-02-06 | Merus Nv | Rekombinant produktion af blandinger af antistoffer |
| WO2005023849A2 (en) | 2003-09-04 | 2005-03-17 | Crucell Holland B.V. | Antigenic peptides of rabies virus and uses thereof |
| EP1686137A4 (en) * | 2003-10-09 | 2009-10-28 | Chugai Pharmaceutical Co Ltd | Method of stabilizing protein solutions |
| EP1688432B1 (en) * | 2003-10-09 | 2011-08-03 | Chugai Seiyaku Kabushiki Kaisha | Igm high concentration stabilized solution |
| EP1712240B1 (en) * | 2003-12-25 | 2015-09-09 | Kyowa Hakko Kirin Co., Ltd. | Stable water-based medicinal preparation containing antibody |
| EP2314620B1 (en) * | 2004-05-27 | 2013-06-05 | Crucell Holland B.V. | Method of identifying binding molecules capable of neutralizing rabies virus |
| EP1871803B1 (en) * | 2005-04-18 | 2013-02-20 | Yeda Research And Development Company Limited | Stabilized anti-hepatitis b (hbv) antibody formulations |
| JP5410985B2 (ja) | 2006-12-05 | 2014-02-05 | クルセル ホランド ベー ヴェー | 液体抗狂犬病抗体製剤 |
-
2007
- 2007-12-04 JP JP2009539730A patent/JP5410985B2/ja not_active Expired - Fee Related
- 2007-12-04 AU AU2007328960A patent/AU2007328960B2/en not_active Ceased
- 2007-12-04 WO PCT/EP2007/063244 patent/WO2008068246A1/en not_active Ceased
- 2007-12-04 EA EA200970533A patent/EA017549B1/ru unknown
- 2007-12-04 CN CN2007800448444A patent/CN101557799B/zh not_active Expired - Fee Related
- 2007-12-04 KR KR1020097013012A patent/KR101522036B1/ko not_active Expired - Fee Related
- 2007-12-04 EP EP07847749.4A patent/EP2088997B1/en active Active
- 2007-12-04 CA CA2668947A patent/CA2668947C/en active Active
- 2007-12-04 MX MX2009005414A patent/MX2009005414A/es active IP Right Grant
- 2007-12-04 US US12/312,967 patent/US7959922B2/en not_active Expired - Fee Related
-
2009
- 2009-04-21 ZA ZA2009/02772A patent/ZA200902772B/en unknown
- 2009-05-27 IL IL199004A patent/IL199004A/en active IP Right Grant
- 2009-06-04 CU CU20090099A patent/CU23795A3/es not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010511665A5 (enExample) | ||
| CN110062620B (zh) | 液体药物组合物 | |
| EP3681483B1 (en) | Process for lyophilized pharmaceutical formulation of a therapeutic protein | |
| JP2000504327A (ja) | 高度に濃縮された、凍結乾燥された、および液体の、因子▲ｉｘ▼処方 | |
| RS66182B1 (sr) | Stabilne višedozne kompozicije koje sadrže antitelo i konzervans | |
| RU2484847C2 (ru) | Лиофилизированный препарат, содержащий гриппозную вакцину, и способ его получения | |
| RU2510279C2 (ru) | Новые защитные композиции для рекомбинантного фактора viii | |
| JP7223712B2 (ja) | 安定なペプチド組成物 | |
| KR20090089881A (ko) | 액체 항-광견병 항체 조성물 | |
| AU6757600A (en) | Rotavirus vaccine formulations | |
| CN107645956B (zh) | 包含阿那白滞素的组合物 | |
| JP7798791B2 (ja) | ウイルス感染症の治療のための肺サーファクタントタンパク質ｄの使用 | |
| WO2025005804A1 (en) | Mucoadhesive formulation | |
| JP2023525565A5 (enExample) | ||
| EP4734957A1 (en) | Mucoadhesive formulation | |
| JP2024543931A5 (enExample) | ||
| AU2008202660B2 (en) | Rotavirus vaccine formulations | |
| JP2023553641A (ja) | 抗ｉｌ５ｒ抗体製剤 | |
| EA043419B1 (ru) | Способ получения лиофилизированного фармацевтического состава на основе терапевтического белка | |
| HK40033832A (en) | Process for lyophilized pharmaceutical formulation of a therapeutic protein | |
| HK40033832B (en) | Process for lyophilized pharmaceutical formulation of a therapeutic protein | |
| CN1897929A (zh) | 包含5－甲基－2－(2′－氯－6′－氟苯胺基)苯乙酸的药物组合物 |